ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFα

Microvascular Research

Volumn 79, Issue 1, 2010, Pages 56-62

  Xing, Junjie ^a   Birukova, Anna A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cytoskeleton; Natriuretic peptide; Pulmonary endothelium; Vascular leak

Indexed keywords

ATRIAL NATRIURETIC FACTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN LIGHT CHAIN PHOSPHATASE; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ENDOTHELIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADHERENS JUNCTIONS; ANTIGENS, CD; ATRIAL NATRIURETIC FACTOR; CADHERINS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG; MITOGEN-ACTIVATED PROTEIN KINASES; MYOSIN-LIGHT-CHAIN PHOSPHATASE; NF-KAPPA B; PHOSPHORYLATION; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73449087606     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2009.11.006     Document Type: Article

References (33)

1. Baxter G.F. The natriuretic peptides. Basic Res. Cardiol. 99 (2004) 71-75
2. Becker P.M., Verin A.D., Booth M.A., Liu F., Birukova A., and Garcia J.G. Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281 (2001) L1500-1511
3. Birukov K.G., Bochkov V.N., Birukova A.A., Kawkitinarong K., Rios A., Leitner A., Verin A.D., Bokoch G.M., Leitinger N., and Garcia J.G. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ. Res. 95 (2004) 892-901
4. Birukova A.A., Chatchavalvanich S., Rios A., Kawkitinarong K., Garcia J.G., and Birukov K.G. Differential regulation of pulmonary endothelial monolayer integrity by varying degrees of cyclic stretch. Am. J. Pathol. 168 (2006) 1749-1761
5. Birukova A.A., Fu P., Chatchavalvanich S., Burdette D., Oskolkova O., Bochkov V.N., and Birukov K.G. Polar head groups are important for barrier protective effects of oxidized phospholipids on pulmonary endothelium. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L924-L935
6. Birukova A.A., Cokic I., Moldobaeva N., and Birukov K.G. Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. Am. J. Respir. Cell Mol. Biol. (2008)
7. Birukova A.A., Zagranichnaya T., Alekseeva E., Bokoch G.M., and Birukov K.G. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. J. Cell Physiol. 215 (2008) 715-724
8. Bogatcheva N.V., Dudek S.M., Garcia J.G., and Verin A.D. Mitogen-activated protein kinases in endothelial pathophysiology. J. Investig. Med. 51 (2003) 341-352
9. Dudek S.M., and Garcia J.G. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91 (2001) 1487-1500
10. Eison H.B., Rosen M.J., Phillips R.A., and Krakoff L.R. Determinants of atrial natriuretic factor in the adult respiratory distress syndrome. Chest 94 (1988) 1040-1045
11. Essler M., Staddon J.M., Weber P.C., and Aepfelbacher M. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling [in process citation]. J. Immunol. 164 (2000) 6543-6549
12. Fu P., Birukova A.A., Xing J., Sammani S., Murley J.S., Garcia J.G., Grdina D.J., and Birukov K.G. Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur. Respir. J. 33 (2009) 612-624
13. Furst R., Brueckl C., Kuebler W.M., Zahler S., Krotz F., Gorlach A., Vollmar A.M., and Kiemer A.K. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ. Res. 96 (2005) 43-53
14. Garcia J.G., Wang P., Schaphorst K.L., Becker P.M., Borbiev T., Liu F., Birukova A., Jacobs K., Bogatcheva N., and Verin A.D. Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. FASEB J. 16 (2002) 1064-1076
15. Imamura T., Ohnuma N., Iwasa F., Furuya M., Hayashi Y., Inomata N., Ishihara T., and Noguchi T. Protective effect of alpha-human atrial natriuretic polypeptide (alpha-hANP) on chemical-induced pulmonary edema. Life Sci. 42 (1988) 403-414
16. Irwin D.C., Tissot van Patot M.C., Tucker A., and Bowen R. Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. Am. J. Physiol. Lung Cell Mol. Physiol. 288 (2005) L849-859
17. Kiemer A.K., Hartung T., and Vollmar A.M. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J. Immunol. 165 (2000) 175-181
18. Kiemer A.K., Weber N.C., Furst R., Bildner N., Kulhanek-Heinze S., and Vollmar A.M. Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ. Res. 90 (2002) 874-881
19. Kim H.J., Lee H.S., Chong Y.H., and Kang J.L. p38 mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225 (2006) 36-47
20. Klinger J.R., Warburton R., Carino G.P., Murray J., Murphy C., Napier M., and Harrington E.O. Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells. Exp. Cell Res. 312 (2006) 401-410
21. Ladetzki-Baehs K., Keller M., Kiemer A.K., Koch E., Zahler S., Wendel A., and Vollmar A.M. Atrial natriuretic peptide, a regulator of nuclear factor-kappaB activation in vivo. Endocrinology 148 (2007) 332-336
22. Liu S., Feng G., Wang G.L., and Liu G.J. p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Eur. J. Pharmacol. 584 (2008) 159-165
23. Lu Y.C., Yeh W.C., and Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 42 (2008) 145-151
24. Lum H., and Malik A.B. Mechanisms of increased endothelial permeability. Can. J. Physiol. Pharmacol. 74 (1996) 787-800
25. Mehta D., and Malik A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86 (2006) 279-367
26. Mitaka C., Hirata Y., Nagura T., Sakanishi N., Tsunoda Y., and Amaha K. Plasma alpha-human atrial natriuretic peptide concentration in patients with acute lung injury. Am. Rev. Respir. Dis. 146 (1992) 43-46
27. Nash S.P., and Heuertz R.M. Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model. Int. Immunopharmacol. 5 (2005) 1870-1880
28. Pedram A., Razandi M., and Levin E.R. Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. J. Biol. Chem. 277 (2002) 44385-44398
29. Petrache I., Crow M.T., Neuss M., and Garcia J.G. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. Biochem. Biophys. Res. Commun. 306 (2003) 244-249
30. Reinhart K., and Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit. Care Med. 29 (2001) S121-125
31. Slotta J.E., Braun O.O., Menger M.D., and Thorlacius H. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo. Inflamm. Res. 55 (2006) 364-367
32. Suwa M., Seino Y., Nomachi Y., Matsuki S., and Funahashi K. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy. Circ. J. 69 (2005) 283-290
33. Tasaka S., Koh H., Yamada W., Shimizu M., Ogawa Y., Hasegawa N., Yamaguchi K., Ishii Y., Richer S.E., Doerschuk C.M., and Ishizaka A. Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632. Am. J. Respir. Cell Mol. Biol. 32 (2005) 504-510